Article | November 2, 2020

Intelligent & Streamlined Drug Product Manufacturing: Assure Scalability, Overcome Regulatory Hurdles & Speed Time To Clinic

Feature

The influx of drug products to the market has remained constant over the past decade. However, the speed and quantity at which novel vaccines, therapeutics, and candidates are currently entering into clinical development is unparalleled. Capacity for manufacturing these products is in high demand.

Clinical timelines in general are usually very fast. The world needs these life-saving therapeutics - and the development and manufacturing industry must be proactively adapting to meet this accelerated demand. The increasing necessity for capacity is intensifying the difficulty for biotech and pharmaceutical companies to identify agile, high-quality services that can deliver as if the world depends on it.

Due to this ever-changing landscape, it is more important than ever to partner with a CDMO that is proactive with how they plan, resource, and execute programs. Reacting to supply chain and general product development challenges as they surface can cost invaluable time, money, and, most importantly, human lives.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Ajinomoto Bio-Pharma Services